Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update

Charles L. Bennett, Bartlett Witherspoon, Kenneth R. Carson*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Progressive multifocal leukoencephalopathy (PML) is a John-Cunningham virus-related central nervous system that is rarely observed in persons treated with the anti-CD20 monoclonal antibody, rituximab.

Original languageEnglish (US)
Title of host publicationCancer Treatment and Research
PublisherSpringer Science and Business Media Deutschland GmbH
Pages103-111
Number of pages9
DOIs
StatePublished - 2022

Publication series

NameCancer Treatment and Research
Volume184
ISSN (Print)0927-3042
ISSN (Electronic)2509-8497

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update'. Together they form a unique fingerprint.

Cite this